We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman Tim-3 Extracellular Domain (Human, Recombinant)
NETA PART: | CAYM-32011-100 |
MFG.PART: | 32011-100 |
UNSPSC: | 12352200 |
Manufacturer: | Cayman |
Product Description
TIM-3 is a member of the T-cell immunoglobulin and mucin-domain containing (TIM) protein family of immunoregulatory proteins and is encoded by the HAVCR2 gene in humans. It is a transmembrane protein composed of an N-terminal immunoglobulin variable (IgV) domain, as well as mucin stalk, transmembrane, and C-terminal cytoplasmic tail domains. The IgV domain contains cysteine residues that form non-canonical intramolecular disulfide bonds resulting in a cleft and channel not found in non-TIM immunoglobulin domains that is important for non-canonical ligand binding. TIM-3 is expressed primarily on T cells but is also expressed on other immune cells such as natural killer and dendritic cells. The TIM-3 ligand galectin 9 (Item No. ), located on immune or tumor cells, binds to glycosylated sites of the IgV and mucin stalk domains and induces TIM-3 oligomerization to activate downstream signaling that impairs immune synapse formation and leads to T cell anergy or apoptosis. The TIM-3 IgV cleft domain binds non-canonical ligands, such as phosphatidylserine on apoptotic cells or CEACAM1 on antigen-presenting or tumor cells.,, TIM-3 is an inhibitory co-receptor that helps maintain immune tolerance but, when expressed on certain cells during chronic infection or cancer, can lead to immune exacerbation. Inhibition of the TIM-3 pathway by Tim-3 fusion or extracellular domain-only proteins prevents the induction of immune tolerance in a mouse islet allograft model or increases weight loss and tissue injury in a mouse model of TNBS-induced colitis, respectively., Expression of TIM-3 is decreased in patients with autoimmune diseases, including ulcerative colitis., TIM-3 is expressed on tumor-infiltrating T cells and expressed on a higher proportion of regulatory T cells from cancer patients. Its overexpression on T cells increases tumor progression in an EL4 mouse model of lymphoma, while TIM-3 inhibition decreases tumor growth in a mouse model of head and neck cancer. SNPs in HAVCR2 are associated with allergic diseases, immunity, and cancer. Caymans TIM-3 Extracellular Domain (human, recombinant) protein is a disulfide-linked homodimer. The reduced monomer, comprised of TIM-3 (amino acids 22-200) fused to mouse IgG1 Fc at its C-terminus, consists of 412 amino acids, has a calculated molecular weight of 46.2 kDa, and a predicted N-terminus of Ser22 after signal peptide cleavage. As a result of glycosylation, the monomer migrates at approximately 50-55 kDa by SDS-PAGE under reducing conditions.
WARNING This product is not for human or veterinary use.
Technical Information
- CD366
- Hepatitis A Virus Cellular Receptor 2 Precursor
- KIM-3
- T Cell Immunoglobulin and Mucin Domain-containing Protein 3
- T Cell Immunoglobulin Mucin Receptor 3
- T Cell Membrane Protein 3
- TIMD-3
Shipping & Storage Information
SKU | CAYM-32011-100 |
---|---|
Supplier Part Number | 32011-100 |
UM | EA |
UNSPSC | 12352200 |
Manufacturer | Cayman |
MSDS URL | https://www.caymanchem.com/msdss/32011m.pdf |
Temperature | -80 |
Refrigerated-Frozen | Frozen |
CountryOfOrigin | US |
ProductLine | CAYM |
Qty | 100 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 2 Business Days |
Hazardous | N |